319
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study

ORCID Icon, , , &
Pages 130-133 | Received 19 Oct 2017, Accepted 30 Nov 2017, Published online: 07 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jinliang Xie, Dingwei Liu, Jianxiang Peng, Shuang Wu, Dongsheng Liu & Yong Xie. (2023) Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline. Expert Review of Anti-infective Therapy 21:4, pages 447-454.
Read now
Davide Giuseppe Ribaldone, Marco Astegiano & Rinaldo Pellicano. (2018) Helicobacter pylori eradication: poor medical compliance from East to West of the world. Scandinavian Journal of Gastroenterology 53:3, pages 265-265.
Read now

Articles from other publishers (26)

Inés Ariño‐Pérez, Samuel J. Martínez‐Domínguez, Enrique Alfaro Almajano, Patricia Carrera‐Lasfuentes & Ángel Lanas. (2023) Mistakes in the diagnosis and treatment of Helicobacter pylori infection in daily clinical practice . Helicobacter 28:4.
Crossref
Jing Yu, Yi-Ming Lv, Peng Yang, Yi-Zhou Jiang, Xiang-Rong Qin & Xiao-Yong Wang. (2023) Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection . World Journal of Gastroenterology 29:20, pages 3133-3144.
Crossref
Jinnan Chen, Yixian Guo, Yu Huang, Zhaohui Ding, Jing Wang, Xiao Liang, Ping Xu, Yaohua Han & Hong Lu. (2023) Rifabutin-Containing Triple Therapy Versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial . The Journal of Infectious Diseases.
Crossref
Mahsa Mohtasham, Farahnaz Joukar, Saman Maroufizadeh, Kourosh Mojtahedi, Mehrnaz Asgharnezhad & Fariborz Mansour-Ghanaei. (2023) Lactobacillus ruteri compared with placebo as an adjuvant in quadruple therapy for Helicobacter pylori eradication: A randomized, double-blind, controlled trial. Arab Journal of Gastroenterology 24:1, pages 40-44.
Crossref
Ben-Gang Zhou, Yu-Zhou Mei, Min Zhang, Xin Jiang, Yao-Yao Li & Yan-Bing Ding. (2023) High-dose dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: a systematic review and meta-analysis with trial sequential analysis . Therapeutic Advances in Gastroenterology 16, pages 175628482211477.
Crossref
Kareem A. Ibrahim, Mona T. Kashef, Tharwat R. Elkhamissy, Mohammed A. Ramadan & Omneya M. Helmy. (2022) Aspartate α-decarboxylase a new therapeutic target in the fight against Helicobacter pylori infection. Frontiers in Microbiology 13.
Crossref
Jing Zha, Yue‐yue Li, Jun‐yan Qu, Xiao‐xiao Yang, Zhong‐xue Han & Xiuli Zuo. (2022) Effects of enhanced education for patients with the Helicobacter pylori infection: A systematic review and meta‐analysis . Helicobacter 27:2.
Crossref
Qiao‐Qiao Shao, Xue‐Chun Yu, Miao Yu, Jing Ma, Jun‐Bo Zhao, Lin Yuan, Ya‐Bin Qi, Ruo‐Bing Hu, Pei‐Ru Wei, Wei Xiao, Ling Lan, Bai‐Ling Jia, Lian‐Zhong Zhang & Song‐Ze Ding. (2022) Rabeprazole plus amoxicillin dual therapy is equally effective to bismuth‐containing quadruple therapy for Helicobacter pylori eradication in central China: A single‐center, prospective, open‐label, randomized‐controlled trial . Helicobacter 27:2.
Crossref
Ben‐Gang Zhou, Xue‐Liang Yan, Lin‐Yan Wan, Qing Zhang, Bo Li & Yao‐Wei Ai. (2022) Effect of enhanced patient instructions on Helicobacter pylori eradication: A systematic review and meta‐analysis of randomized controlled trials . Helicobacter 27:2.
Crossref
Olga P. Nyssen, Dino Vaira, Bojan Tepes, Limas Kupcinskas, Dmitry Bordin, Ángeles Pérez-Aisa, Antonio Gasbarrini, Manuel Castro-Fernández, Luis Bujanda, Ana Garre, Alfredo Lucendo, Liudmila Vologzhanina, Natasa B. Jurecic, Luis Rodrigo-Sáez, Jose M. Huguet, Irina Voynovan, Jorge Perez-Lasala, Pilar Mata Romero, Miroslav Vujasinovic, Rustam Abdulkhakov, Jesús Barrio, Luis Fernandez-Salazar, Francis Mégraud, Colm O’Morain & Javier P. Gisbert. (2022) Room for Improvement in the Treatment of Helicobacter pylori Infection. Journal of Clinical Gastroenterology 56:2, pages e98-e108.
Crossref
Luis Fernando Valladales-Restrepo, Yessenia Correa-Sánchez, Brayan Stiven Aristizábal-Carmona & Jorge Enrique Machado-Alba. (2022) Treatment regimens used in the management of Helicobacter pylori in Colombia. The Brazilian Journal of Infectious Diseases 26:1, pages 102331.
Crossref
Tarang Taghvaei, Negin Kamali, Amin Talebi Bezmin Abadi, Farid Rahimi & Mojgan Forootan. (2021) Isolation of dupA-positive and clarithromycin-resistant Helicobacter pylori from Iranian patients with duodenal ulcer. Gene Reports 24, pages 101228.
Crossref
Majid T. Moghadam, Zahra Chegini, Amin Norouzi, Amin S. Dousari & Aref Shariati. (2021) Three-Decade Failure to the Eradication of Refractory Helicobacter pylori Infection and Recent Efforts to Eradicate the Infection. Current Pharmaceutical Biotechnology 22:7, pages 945-959.
Crossref
Siya Kong, Han Chen, Keting Huang, Duochen Jin, Guoxin Zhang & Feng Ye. (2021) Antibiotic susceptibility guided reuse of levofloxacin-based therapy in a penicillin-allergic patient for Helicobacter pylori infection. Medicine 100:10, pages e24915.
Crossref
Yao Chen, Hongxun Yuan, Hui Ye, Zongming Shi, Xin Deng, Xuezhi Zhang & Xikang Hou. (2021) Application of a semi‐automatic, intensive follow‐up for improving efficacy and adherence of Helicobacter pylori eradication therapy: A randomized controlled trial . MicrobiologyOpen 10:1.
Crossref
Anabel Liyen Cartelle, Pearl Princess Uy, Tara E Koehler & John Erikson L Yap. (2020) Persistent Helicobacter pylori Infection: An Insight to the Limitations of Current Clinical Practice. Cureus.
Crossref
Mijung Lee, Jin-Young Chung, Ka Yeun Kim, Wooseok Im & Manho Kim. (2020) Two-weeks repeated-dose oral toxicity study of Pediococcus acidilactici J9 in a mice model. BMC Microbiology 20:1.
Crossref
Lyudmila Boyanova, Rumyana Markovska, Petyo Hadzhiyski, Nayden Kandilarov & Ivan Mitov. (2020) Rifamycin use for treatment of Helicobacter pylori infection: a review of recent data . Future Microbiology 15:12, pages 1185-1196.
Crossref
Javier P. Gisbert. (2020) Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review . Therapeutic Advances in Gastroenterology 13, pages 175628482096873.
Crossref
Hyasinta Jaka, Andreas Mueller, Christa Kasang & Stephen E. Mshana. (2019) Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study. BMC Infectious Diseases 19:1.
Crossref
Erick A. Argueta & Steven F. Moss. (2019) Treatment of Helicobacter pylori. Current Opinion in Gastroenterology 35:6, pages 544-550.
Crossref
Sinéad M. Smith, Colm O’Morain & Deirdre McNamara. (2019) Helicobacter pylori resistance to current therapies. Current Opinion in Gastroenterology 35:1, pages 6-13.
Crossref
Neil R. O'Morain, Maria P. Dore, Anthony J. P. O'Connor, Javier P. Gisbert & Colm A. O'Morain. (2018) Treatment of Helicobacter pylori infection in 2018 . Helicobacter 23, pages e12519.
Crossref
Rinaldo Pellicano & Carlo A. Fallone. (2018) Helicobacter pylori: what are the challenges of today and in the years to come?. Minerva Gastroenterologica e Dietologica 64:3.
Crossref
Jae Ho Choi, Young Joo Yang, Chang Seok Bang, Jae Jun Lee & Gwang Ho Baik. (2018) Current Status of the Third-Line Helicobacter pylori Eradication . Gastroenterology Research and Practice 2018, pages 1-7.
Crossref
Tae Ho Kim. (2018) Is It Better to Take a Proton Pump Inhibitor before a Meal for Helicobacter pylori Eradication? . The Korean Journal of Helicobacter and Upper Gastrointestinal Research 18:2, pages 79.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.